BioXcel Therapeutics, Inc. Common Stock (BTAI)
BioXcel Therapeutics, Inc. (BTAI) is a biotechnology company focused on the development and commercialization of artificial intelligence-driven therapies for neuroscience and immuno-oncology indications. The company utilizes its proprietary platform to identify and develop innovative drug candidates, aiming to address unmet medical needs in areas such as acute neuropsychiatric disorders and cancer.
Company News
BioXcel Therapeutics will ring the Nasdaq Closing Bell to celebrate its breakthrough progress in treating agitation associated with bipolar disorders and schizophrenia, highlighting the successful completion of its SERENITY At-Home pivotal trial.
Three stocks - BioXcel Therapeutics, Telos, and Jumia - have shown significant momentum gains, with substantial price increases and strong performance in Benzinga's momentum rankings over the past week.
Penny stocks to watch this week. The post 5 Most Active Penny Stocks Today & Why They’re Moving Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Audit findings support application for approval of treatment for Alzheimer's-related agitation, company says
The company's co-founder is leaving, and layoffs are coming.